Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The displayed Revision tag has been updated to v3.6.6, replacing the previous v3.6.5, indicating a software revision rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-09-01T18:08:03.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page. The update does not alter the study content, eligibility criteria, or results on the page.
    Difference
    0.0%
    Check dated 2026-08-11T08:29:46.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a small editorial update. This change reflects metadata updates rather than modifications to the study details or results.
    Difference
    0.0%
    Check dated 2026-07-28T03:06:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.6.3 appears on the study page, replacing the previous v3.6.2, indicating a version update of the ClinicalTrials.gov record.
    Difference
    0.0%
    Check dated 2026-07-06T16:45:07.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page displays a newer revision tag (v3.6.2) replacing the previous v3.6.0. This reflects a minor backend or template update rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-06-29T10:48:17.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    The enrollment status now shows that the study is no longer looking for participants. The page adds guidance sections to help readers understand and participate, and the revision note updates to v3.6.0 with a formatting adjustment for the Intervention/Treatment heading.
    Difference
    0.4%
    Check dated 2026-06-15T05:23:55.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.